Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
133
datasets available to search
ShareScore release 0.9.0
Dataset results
133 results for “Health Economics”
Outcomes and Health Economics of Stroke Using Rhythmic Auditory Stimulation
ClinicalTrials.gov study NCT06051539. IPD Sharing: NO. Countries: 1. Publications: 1.
4EVER - Efficacy, Safety, Health Economics, Translational Research of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer
ClinicalTrials.gov study NCT01626222. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Economic Evaluation of Periodic Occupational Health Screening
ClinicalTrials.gov study NCT04684316. IPD Sharing: NO. Countries: 1. Publications: 3.
Data from: Screening primary-care patients forgoing health care for economic reasons
Open the record for dataset details and reuse information.
Data from: Economic costs and health-related quality of life for hand, foot and mouth disease (HFMD) patients in China
Open the record for dataset details and reuse information.
Data from: Geo-clustered chronic affinity: pathways from socio-economic disadvantages to health disparities
Open the record for dataset details and reuse information.
Public health and economic benefits of spotted hyenas (Crocuta crocuta) in a peri-urban system
<p>Species that depend on anthropogenic waste for food can remove pathogens that pose health risks to humans and livestock, thereby saving lives and money. Quantifying these benefits is rare, yet can lead to innovative conservation solutions.</p> <p>To assess these benefits, we examined the feeding ecology and population size of peri-urban spotted hyenas (<i>Crocuta crocuta</i>) in Mekelle, Ethiopia. We integrated these field data into a disease transmission model to predict: a) the number of anthrax and bovine tuberculosis (bTB) infections arising in humans and livestock from infected carcass waste, and b) the costs associated with treating these infections and losing livestock. We compared these public health and economic outcomes under two scenarios: a) hyenas are present, and b) the counterfactual, hyenas are absent.</p> <p>We estimated that hyenas annually remove 4.2% (207 tonnes) of the total carcass waste disposed of by residents and businesses in Mekelle. Furthermore, the scavenging behaviour of hyenas annually prevents five infections of anthrax and bTB in humans, and 140 infections in cattle, sheep and goats. This disease control service potentially saves USD 52,165 due to the treatment costs and livestock loss avoided.</p> <p><i>Synthesis and applications</i>. This human-hyena interaction in Ethiopia is evidence that large carnivores can contribute to human health and economy. To retain these benefits and maintain tolerance of hyenas, we recommend: introducing education programs to promote safe outdoor behaviour around hyenas, training watchdogs to alert residents of hyena presence, constructing bomas to protect livestock from hyena attacks, and preserving the hyenas' access to carcass waste to reduce their dependency on livestock predation. With humans and carnivores coming more frequently into contact, understanding and communicating how these species can benefit humanity will be critical to motivating human-carnivore coexistence worldwide.</p>
Data from: The interrelationship among economic activities, environmental degradation, material consumption, and population health in low-income countries: a longitudinal ecological study
Objectives: The theory of ecological unequal exchange explains how trade and various forms of economic activity create the problem of environmental degradation, and lead to the deterioration of population health. Based on this theory, our study examined the inter-relationship among economic characteristics, ecological footprints, CO2 emissions, infant mortality rates and under-5 mortality rates in low-income countries. Design: A longitudinal ecological study design. Setting: Sixty-six low-income countries from 1980 to 2010 were included in the analyses. Data for each country represented an average of 23 years (N=1497). Data sources: Data were from the World Development Indicators, UN Commodity Trade Statistics Database, Global Footprint Network and Polity IV Project. Analyses: Linear mixed models with a spatial power covariance structure and a correlation that decreased over time were constructed to accommodate the repeated measures. Statistical analyses were conducted separately by sub-Saharan Africa, Latin America and other regions. Results: After controlling for country-level sociodemographic characteristics, debt and manufacturing, economic activities were positively associated with infant mortality rates and under-5 mortality rates in sub-Saharan Africa. By contrast, export intensity and foreign investment were beneficial for reducing infant and under-5 mortality rates in Latin America and other regions. Although the ecological footprints and CO2 emissions did not mediate the relationship between economic characteristics and health outcomes, export intensity increased CO2 emissions, but reduced the ecological footprints in sub-Saharan Africa. By contrast, in Asia, the Middle East and North Africa, although export intensity was positively associated with the ecological footprints and also CO2 emissions, the percentage of exports to high-income countries was negatively associated with the ecological footprints. Conclusions: This study suggested that environmental protection and economic development are important for reducing infant and under-5 mortality rates in low-income countries.
Health care-related economic burden of polycystic ovary syndrome in the United States: Pregnancy-related and long-term health consequences - supplemental data
<p><b>Context: </b>Polycystic ovary syndrome (PCOS) is the most common endocrine disorder of reproductive-aged women, affecting approximately 5-20% of women of reproductive age. A previous estimate noted that the economic burden of PCOS approximates $3.7 billion annually in 2020 USD when considering only the costs of the initial diagnosis and of reproductive endocrine morbidities, not considering the costs of pregnancy-related and long-term morbidities.</p> <p><span><span><span><span><span><span><span><span><b>Objective: </b>To estimate the excess prevalence and economic burden of pregnancy-related and long-term health morbidities attributable to PCOS.</span></span></span></span></span></span></span></span></p> <p><span><span><span><span><span><span><span><span><b>Data Sources: </b>PubMed, EmBase and Cochrane Library.</span></span></span></span></span></span></span></span></p> <p><span><span><span><span><span><span><span><span><b>Study Selection: </b>Studies in which the diagnosis of PCOS was consistent with the Rotterdam, National Institutes of Health (NIH), or Androgen Excess & PCOS (AE-PCOS) Society criteria, or that used electronic medical record diagnosis codes, or diagnosis based on histopathologic sampling were eligible for inclusion. Studies that included an outcome of interest and a control group of non-PCOS patients who were matched or controlled for body mass index (BMI) were included. </span></span></span></span></span></span></span></span></p> <p><span><span><span><span><span><span><span><span><b>Data Extraction: </b>Two investigators working independently extracted data on study characteristics and outcomes. </span></span></span></span></span></span></span></span></p> <p><span><span><span><span><span><span><span><span><b>Data Synthesis: </b>Data was pooled using random-effects meta-analysis. The I <sup>2 </sup>statistic was used to assess inter-study heterogeneity. The quality of selected studies was assessed using the Newcastle-Ottawa Scale.</span></span></span></span></span></span></span></span></p> <p><span><span><span><span><span><span><span><span><b>Results: </b>The additional total healthcare-related economic burden due to pregnancy-related and long-term morbidities associated with PCOS in the United States is estimated to be $4.3 billion annually in 2020 USD.</span></span></span></span></span></span></span></span></p>
Master Protocol to Study Treatment Patterns, Medication Adherence, Health and Economic Outcomes and Unmet Needs in RCC
ClinicalTrials.gov study NCT04375150. IPD Sharing: NO. Countries: 1. Publications: 0.
Phaco Versus Small Incision Cataract Surgery (SICS) Health Economic Study
ClinicalTrials.gov study NCT00762606. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Economic and Psychological Burden of Infertility Among Women Attending Women Health Hospital, Assiut University
ClinicalTrials.gov study NCT06664086. IPD Sharing: Not stated. Countries: 0. Publications: 2.
Quality of Life and Health Economic Measurements in Allergic Patients Treated With Immunotherapy
ClinicalTrials.gov study NCT01486498. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Health-economic Evaluation of Interventional Pain Management Compared to Pain Rehabilitation
ClinicalTrials.gov study NCT04657159. IPD Sharing: NO. Countries: 1. Publications: 0.
Assessment of Infection Control, Practice Efficiency, and Health Economics of Sheathed Versus Standard Cystoscopy
ClinicalTrials.gov study NCT02922868. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Health Economic Trial in Adult Patients Undergoing Ileostomy Reversal MA402S23B504
ClinicalTrials.gov study NCT01509807. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Health Economics Evaluation of Catheter Ablation Versus Drug Therapy in Atrial Fibrillation (AF) in China
ClinicalTrials.gov study NCT01878981. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Data from: The interrelationship among economic activities, environmental degradation, material consumption, and population health in low-income countries: a longitudinal ecological study
Open the record for dataset details and reuse information.
Data from: Screening of health care workers for tuberculosis: development and validation of a new health economic model to inform practice
Open the record for dataset details and reuse information.
Public health and economic benefits of spotted hyenas (Crocuta crocuta) in a peri-urban system
Open the record for dataset details and reuse information.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.